Point72 Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1791 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1917 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2234 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2265 |
|
|
2023
Q2 | – | Sell |
-111,400
| Closed | -$2.72M | – | 2288 |
|
|
2023
Q1 | $2.72M | Sell |
111,400
-291,729
| -72% | -$7.12M | 0.01% | 767 |
|
|
2022
Q4 | $12.7M | Sell |
403,129
-681,111
| -63% | -$21.5M | 0.04% | 441 |
|
|
2022
Q3 | $30.6M | Buy |
1,084,240
+881,940
| +436% | +$24.9M | 0.12% | 213 |
|
|
2022
Q2 | $5.35M | Buy |
+202,300
| New | +$5.35M | 0.02% | 594 |
|
|
2021
Q4 | – | Sell |
-141,400
| Closed | -$4.17M | – | 1284 |
|
|
2021
Q3 | $4.17M | Sell |
141,400
-227,150
| -62% | -$6.7M | 0.02% | 643 |
|
|
2021
Q2 | $9.44M | Buy |
368,550
+71,850
| +24% | +$1.84M | 0.04% | 436 |
|
|
2021
Q1 | $4.07M | Buy |
296,700
+176,700
| +147% | +$2.43M | 0.02% | 571 |
|
|
2020
Q4 | $1.99M | Buy |
+120,000
| New | +$1.99M | 0.01% | 688 |
|